BOLLWERK AI: some red flags we spotted in VOYG most recent S-1 filings

Offer amount is ~$345.4M. Here’s a quick summary of some red flags we spotted in their most recent S-1 filings. 📝

ImageImage

ImageImage

ImageImage

⚠️ Disclaimer: Just because we're posting this summary does not mean it's a smart idea to short any IPO, let alone in the current investing climate. In any case, here goes:

💸 Persistent and Widening Net Losses:

  • Net loss attributable to Voyager Technologies, Inc. was $62.1 million in 2024 (up from $25.4 million in 2023) and $26.9 million for Q1 2025 (up from $14.8 million in Q1 2024).

  • Loss before income taxes was $67.3 million in 2024 (up from $24.9 million in 2023).

  • Accumulated deficit stood at $308.1 million as of March 31, 2025.

💸 Negative and Worsening Cash Flow from Operations:

  • Cash used in operating activities was $25.5 million for the year ended Dec 31, 2024 (an increase from $15.4 million in 2023).

  • For Q1 2025, cash used was $14.4 million (worsening from $7.9 million in Q1 2024).

👑 Highly Concentrated Voting Control by CEO & Controlled Company Status:

  • Post-IPO, Dylan Taylor will control approximately 63.4% to 65.1% of the voting power (despite owning ~10.3% of capital stock) due to Class B common stock having 15 votes per share.

  • A single share of Class A Preferred Stock held by the CEO also grants votes equal to all other equity combined plus one.

  • This makes Voyager a "controlled company" under NYSE rules, allowing potential governance exemptions.

🚀 Starlab Project: Significant Funding Uncertainty, Execution Risks, Pre-Revenue Status, and High Costs:

  • Estimated cost $2.8-$3.3 billion. Currently pre-revenue.

  • Only $70.3 million of $217.5 million NASA grant funding remained as of March 31, 2025.

  • Significant execution risks (no prior experience, reliance on unproven SpaceX Starship).

  • Starlab segment reported $0 net sales (2023, 2024) with Segment Adjusted EBITDA swinging from 12.6M(2023)to(8.3M) (2024).

  • $90M non-cancelable launch service contract with potential $13.5M termination fee.

govt.US 🇺🇸 Heavy Reliance on U.S. Government Contracts and Funding:

  • Approximately 83.9% of revenues in 2024 (up from 68.7% in 2023) and 85.6% in Q1 2025 were derived from U.S. government contracts.

  • NASA represented 25.6% of revenue in 2024.

  • Starlab project is heavily dependent on NASA funding.

📈 Immediate and Substantial Shareholder Dilution (IPO & Future):

  • IPO price ($27.50 midpoint) is substantially higher than pro forma as adjusted net tangible book value ($6.60), resulting in immediate dilution of $20.90 per share.

  • Significant future dilution potential from "evergreen" provisions in equity plans (5% and 1% annual increases), $25.0M SMI Promissory Notes payable in equity, $10.1M 2024 Convertible Notes converting at a discount, and recent post-balance sheet equity issuances.

💸 Negative and Declining Adjusted EBITDA:

  • Adjusted EBITDA was (21.4)millionforQ12025(downfrom(7.2) million in Q1 2024).

  • For YE 2024, Adjusted EBITDA was $(30.0) million (down from $1.4 million in YE 2023).

  • Total Segment Adjusted EBITDA also declined from 17.0millionin2023to(3.4) million in 2024.

💸 Negative Free Cash Flow:

  • Free cash flow was (23.3)millionforQ12025and(53.3) million for YE 2024, indicating cash consumption after capital expenditures.

💸 High Cost of Debt, Refinancing Risk, and Significant Repayment Obligations:

  • $58.0M Term Loan (June 2024) bears high variable interest (WSJ Prime/8.50% + 1.25%) plus 2.50% PIK interest, with prepayment penalties.

  • Intends to repay with new Revolving Credit Facility.

  • Total future principal payments for term loan: $65.97M, with significant amounts due 2026-2028.

💸 Escalating Cumulative Dividends on Redeemable Preferred Stock:

  • Class A-1 Redeemable Preferred Stock accrues cumulative dividends (8% initial, rising to 16% annually).

  • Accrued dividends increased from $10.1M (2023) to $13.3M (2024).

  • Carrying value $93.5M at Dec 31, 2024.

  • These are preferential claims senior to common stock.

💸 Significant and Increasing Valuation Allowance Against Deferred Tax Assets:

  • Valuation allowance against DTA increased from $23.3 million (Dec 31, 2023) to $40.3 million (Dec 31, 2024), indicating it's more likely than not that these tax assets (from NOLs) will not be realized, suggesting doubts about future profitability.

💸 Potential for Future Stock Sales Post-Lock-Up to Depress Market Price:

  • Substantial number of shares (~45.5% of Class A covered by registration rights, plus 38,348,800 additional shares) become eligible for sale after 180-day lock-up, potentially causing price decline.

🚀 Invest with Caution! 🚀


For SG users only, A tool to boost your purchasing power and trading ideas with CashBoost!

Open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.

Other helpful links:

# Saint Bella Surging 40%: Next Big Thing is IFBH?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet